 NGM Biopharmaceuticals NYSE:NGM Director Group L. P. Column purchased 732 shares of the stock in a transaction on Thursday, July 30th. The shares were purchased at an average cost of 17.99 per share, with a total value of 13,168.68. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. ... 